A patient with repaired double outlet right ventricle presented during early gestation with heart failure symptoms due to severe right ventricle-pulmonary artery conduit stenosis and insufficiency. In the first trimester, she underwent transcatheter therapy with Melody pulmonary valve implantation with excellent hemodynamic results and completed pregnancy without significant maternal complications. (Level of Difficulty: Advanced.) (J Am Coll Cardiol Case Rep 2020;2:135-8)
I n women with congenital heart disease (CHD), hemodynamic changes of pregnancy can threaten maternal and fetal life (1, 2) . Maternal cardiac output rises by 30% to 50% above baseline during pregnancy, thus increasing pressure overload from preexisting valve stenosis, leading to ventricular strain, heart failure, and arrhythmias. Mechanical relief of pressure overload due to valve stenosis should improve maternal outcomes. Most studies of valvular disease in pregnancy involve acquired aortic or mitral valve disease, rather than CHD, with little research on pulmonary valve replacement (PVR) in pregnancy.
HISTORY OF PRESENTATION
A 20-year-old primigravida with repaired double outlet right ventricle presented at 6 weeks' gestation with dichorionic twins. The patient had a body mass index of 42 kg/m 2 with New York Heart Association functional class II symptoms and loud systolic and diastolic murmurs on examination.
MEDICAL HISTORY
Prior surgeries included a Rastelli procedure at age 4 years, when an aortic valve homograft was used for the right ventricle-pulmonary artery conduit (RVPAC) and at 12 years of age, the RVPAC was replaced with a 22-mm Contegra (Medtronic, Inc., Minneapolis, Minnesota) conduit.
LEARNING OBJECTIVES
To understand the implication of conduit stenosis and valvular insufficiency in pregnant patients. To be able to weigh the risks and benefits of percutaneous valve replacement as a viable option in pregnant women with complex congenital heart disease. However, CPB during pregnancy is very high risk and
is associated with a 30% fetal loss rate (3).
Catheterization-based techniques are commonly used in rheumatic heart disease, and as a result, To our knowledge, there is only one other published case of successful TPV implantation during pregnancy (7) . Although it is always preferable to perform congenital heart interventions in the nonpregnant state, an unfortunately large number of patients are "lost to care" for a variety of reasons and do not have valve reintervention done in a timely fashion before pregnancy. We believe this report highlights the usefulness of percutaneous valve therapy as an approach that provides more options to pregnant women with CHD.
FOLLOW-UP
The patient has been followed for 3 years since delivery and her most recent echocardiogram 2 years after TPV implantation showed an excellent result with peak and mean gradients of 17 mm Hg and 9 mm Hg, respectively, across the RVPAC and only trace regurgitation.
CONCLUSIONS
TPV implantation of a Melody valve can be safely done during pregnancy with excellent hemodynamic and pregnancy outcomes, as described in this report.
Because of a growing population of patients with CHD reaching reproductive age, as well as the epidemic of patients "lost to follow-up" who present in an already pregnant state with significant valve problems, we expect use of TPV implantation techniques to become more common and crucial in reducing maternal and fetal mortality in the future.
